coordination, dysarthria, or disturbed eye movements. Heredoataxias are most frequently classified according to the mode of inheritance (AD, AR, or XL) 6 . Mitochondrial disorders with ataxia as part of the phenotype may also be inherited via an AD, AR, XL or maternal trait but have gained little attention so far. With the rapidly increasing prevalence of MIDs, however, an increasing number of MIDs with ataxia are reported. This review aims to give an overview of recent advances and current knowledge about the frequency, clinical presentation, genetic background, management, and prognosis of hereditary MIDs associated with sensory, spinal, or cerebellar ataxia.
METHODS
The source of the disorders listed below was a MEDLINE search covering the years 1966 to February 2009 and using the key words: ataxia, sensory ataxia, cerebellar ataxia, mitochondrial respiratory chain, mitochondrial disorder, and all acronyms of syndromic MIDs listed in Table 1 .
Definitions
Ataxia was defined as uncoordination and unsteadiness due to cerebral failure to regulate the body's posture or regulate strength and direction of limb movements 7 . Ataxia is usually a manifestation of a cerebral disorder, particularly of the cerebellum (cerebellar ataxia) or due to a spinal or peripheral lesion (sensory ataxia). Cerebellar and sensory ataxia manifest as uncoordinated movements, or unsteady stance and gait. Additional manifestations of cerebellar ataxia may be nystagmus or dysarthria, which often distinguish central and peripheral ataxia. Sensory ataxia can be compensated by opening the eyes, whereas cerebellar ataxia persists with open or closed eyes 7 .
Frequency of mitochondrial ataxias
No convenient figures are reported about the prevalence of ataxia in MIDs. Only figures about the general prevalence of MIDs are available, estimating that 9/100,000 individuals have a manifest MID 8 . Additionally, 16.5/100,000 children and adults are at risk for the development of a MID 8 . The prevalence of the MERRF mutation 8344A>G in North East England is 0.4/100000 8 . The most common POLG1 mutation, 467A>T, has been reported to occur in 0.6% of the Belgian population 9 .
Classification of mitochondrial disorders
Most frequently, MIDs are classified according to the type of the mutated gene. A first group of MIDs is due to mutations in mtDNA located genes ( Table 2 ). Mitochondrial disorders due to mtDNA mutations are further classified as MIDs due to point mutations, which are maternally inherited and homoplasmic or exclusively heteroplasmic (Table 2) , or as single deletions or duplications, which are sporadic and heteroplasmic. Point mutations may either affect tRNA or rRNA genes (MELAS, MERRF) or genes encoding for RC subunits (LHON, NARP, MILS). Single deletions or duplications are responsible for CPEO, PS, or KSS 2 . The second group of MIDs is due to mutations in nDNA located genes, which are divided into genes encoding for RC subunits (LS, non-syndromic MID), for assembly factors of RC subunits (LS, GRACILE syndrome), for proteins involved in intergenomic signaling, causing breakage syndromes (AD-CPEO, AR-CPEO, SANDO, SCAE, AHS, MNGIE), depletion syndromes (non-syndromic MID, AHS), or translation defects (MLASA), for proteins involved in the CoQ metabolism (LS, non-syndromic MID), for proteins involved in the mitochondrial transport machinery (X-linked DDS (MTS) THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES 544 10 .
Diagnosis of mitochondrial disorders
The diagnosis of a MID is based on clinical, chemical, electrophysiological, histological, biochemical, and genetic investigations. Phenotypic features suggesting a MID include abnormalities of the PNS (myopathy including ocular muscles, neuropathy, neuronopathy), CNS (epilepsy, migraine, stroke-like episodes, ischemic stroke, ataxia, Parkinsonism, dystonia, optic atrophy, cognitive decline, psychiatric abnormalities, coma), endocrine glands (short stature, pituitary adenoma, pituitary insufficiency, thyroid dysfunction, hypoparathyroidism, diabetes mellitus, hyponatriemia, hypogonadism, hyperhidrosis, osteoporosis), heart (cardiomyopathy, impulse generation or propagation abnormalities), eye (cataract, glaucoma, retinitis pigmentosa), ear (hypoacusis, tinnitus, vertigo), gastrointestinal tract (vomiting, pseudoobstruction, diarrhea, hepatopathy, liver cysts, pancreatitis), kidney (renal failure, renal cysts), bone marrow (anemia, leucopenia, thrombocytopenia, pancytopenia), bones (facial dysmorphism, hypertelorism), or dermis (lipoma, psoriasis, excema 
Mitochondrial disorders associated with ataxia

A. Disorders due to mutations in mtDNA genes
Mitochondrial encephalomyopathy, lactacidosis, stroke-like episodes (MELAS)
Ataxia is not a common feature of MELAS syndrome, but has been reported in single patients. In a female with a MELAS phenotype since childhood, cognitive impairment and ataxia developed during the disease course (Table 3) 11 . In this patient MELAS was due to the 7512T>C tRNASer mutation 11 . Ataxia has been also reported in a MELAS patient carrying the 3243A>G mutation (Table 4) 12 .
Myoclonic epilepsy and ragged red fibers (MERRF)
Cerebellar ataxia is a common feature of MERRF syndrome. Nearly all MERRF patients present with cerebellar ataxia 13 . Cerebellar ataxia may be even the presenting manifestation in quite a number of patients (Table 3) 14 . In addition, MERRF patients typically present with myoclonic epilepsy, and mitochondrial myopathy with ragged-red fibers 15 . More rarely patients develop dementia, parkinsonism, hypoacusis, optic atrophy, multiple lipomas, or foot deformities in the advanced stages 13, 16, 17 . On cerebral magnetic resonance imaging (cMRI) atrophy of the cerebellar peduncles, the cerebellum, or the brainstem can be found 14 . Histopathological findings include degeneration of the dentate nuclei, globus pallidus, red nuclei, substantia nigra, inferior olivary nuclei, cerebellar cortex, or spinal cord. Particularly the posterior columns, the spinocerebellar tracts, or Clarc's columns are affected 16 . MERRF is most frequently due to point mutations in the tRNALys gene (Table 4 ).
Leber's hereditary optic neuropathy (LHON)
Only in single patients ataxia may be a supplementary feature in addition to optic atrophy (Table 3) 18, 19 . In such patients cMRI may reveal cerebellar atrophy 19 . LHON is due to homoplasmic mtDNA mutations affecting genes, which encode for subunits of RC complex I, III, IV, or V. Most frequently subunits of RC complex I are mutated in LHON. There are three primary LHON mutations, 3460A>G, 11778A>G, and 14484T>C, which account for >95% of the cases (Table 4) 5,20 . Only 50% of males and 10% of females, harboring a primary LHON-mutation, actually develop LHON 20 . The incomplete penetrance and the predominance of males suggest factors other than the primary LHON mutations (secondary LHON mutations, nDNA mutations) play a modifying role.
Neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP)
The cardinal clinical features of NARP include neuropathy, cerebellar ataxia, and retinitis pigmentosa (Table 3) 21 . Additional features include developmental delay, dementia, epilepsy, deafness, sensory neuropathy, or weakness 22 . Neuropathological findings comprise symmetrical lesions in the basal ganglia and brainstem, resembling those of LS 23,24. The syndrome is most frequently caused by heteroplasmic point mutations in the ATP6 gene (Table 4) 21 . The mutation load is particularly high in the cortex, putamen, thalamus, cerebellum, and brainstem 24 . Irrespective of the mutation load the ATP6 activity is reduced by about half of the normal value 25 . 
Maternally inherited Leigh syndrome (MILS)
Ataxia is present in nearly all patients with MILS. However, there is broad clinical and genetic heterogeneity. In a family carrying a mitochondrial ATP6 mutation, clinical manifestations ranged from late-onset MILS to NARP 26 . In another patient the 8993T>C mutation caused MILS at early infancy, which disappeared over time, such that he was near normal at age 18 years 21 . Maternally inherited Leigh syndrome with predominant ataxia and neuropathy was diagnosed in a family carrying the 9185T>C mutation in the ATP6 gene with a heteroplasmy rate >90% (Table 3) 27 . Other ATP6 mutations may also cause MILS and ataxia may be the only manifestation in mutation carriers 28 . Mito-chondrial genes most frequently mutated in MILS are the ND1-6, ATP6, COXIII, and tRNALys genes (Table 4) 29 .
The mutation load correlates positively with the severity of the phenotype 30 .
Pearson syndrome (PS)
Pearson syndrome is an uncommon syndromic MID in infants, characterized by pancytopenia 31 . With disease progression, however, patients additionally develop muscle hypotonia, developmental delay, ataxia, tremor, hepatopathy, renal failure, or exocrine pancreatic dysfunction 31, 32 . Later on the phenotype may even turn into KSS or LS 31 . Muscle biopsy may show features of mitochondrial myopathy 32 . So far about 60 cases have been reported in the literature 31 . As with KSS and CPEO, PS is due to single large-scale mtDNA deletions or duplications 31, 32 .
Kearns-Sayre syndrome (KSS)
Typical features of KSS include CPEO, pigmentary retinopathy, and cardiac conduction disturbances 33 . Additional features include short stature, glaucoma, deafness, diabetes, primary amenorrhea, myopathy with ptosis and limb weakness, pyramidal signs, ataxia, and increased CSF protein content (Table 3) 33, 34 . In single patients KSS may be dominated by an ataxic syndrome 34 . In accordance with the clinical findings, MRI often shows cerebellar or global atrophy. Additionally, there may be T2-hyperintensities in the deep gray matter nuclei, the cerebellar white matter, or the subcortical white matter 35 . Kearns-Sayre syndrome is due to single large-scale mtDNA deletions or duplications 35 .
Maternally inherited diabetes and deafness (MIDD)
Maternally inherited diabetes and deafness syndrome presents clinically with diabetes and sensorineural hearing loss 36 . There are also families, which additionally present with features of MELAS syndrome 37 , including seizures, migraine, short stature, mental retardation, or stroke-like-episodes 38 . In single cases, ataxia may be a feature of the phenotype (Table 3) 39 . Maternally inherited diabetes and deafness is due to mutations in the tRNALeu or tRNALys gene or due to large-scale tandem duplications or deletions/duplications (Table 4) 36, 37 .
Multiple symmetric lipomatosis (MSL)
Multiple symmetric lipomatosis is a rare condition presenting with CPEO, hypoacusis, cerebellar ataxia, proximal myopathy, and polyneuropathy ( geneous, but a frequent mutation causing MSL is the 8344A>G transition in the tRNALys gene (Table 4) 40 .
Non-syndromic MIDs
In a family with the heteroplasmic tRNAIle gene mutation 4284G>A the index patient's mother showed truncal ataxia, dysarthria, severe hearing loss, mental retardation, ptosis, ophthalmoparesis, distal myoclonus, and diabetes mellitus. RC complex I and IV activities were low in the muscle of the affected mother of the index patient 41 . Ataxia was also a feature in an Italian family with lipomas due to the mtDNA mutation 8363G>A 42 . Ataxia was also a phenotypic manifestation of the 14680C>A mtDNA mutation in a 14-year-old boy with exercise intolerance, weakness and lactic acidosis, who showed a mosaic pattern of succinate dehydrogenase staining on muscle biopsy 43 .
B. MIDs due to nDNA mutations
Leigh syndrome (LS)
Leigh syndrome, also termed subacute, necrotizing encephalopathy, is the most frequent MID in childhood 44 . It is clinically characterized by a wide variety of abnormalities from severe neurological problems to almost absence of any abnormality. Most frequently the CNS is affected, including psychomotor retardation, seizures, nystagmus, ophthalmoparesis, optic atrophy, ataxia, dystonia, or respiratory failure (Table 3) 45 . Some patients additionally present with polyneuropathy or myopathy, or non-neurological abnormalities, such as diabetes, short stature, hypertrichosis. cardiomyopathy, anemia, renal failure, vomiting, or diarrhea (Leigh-likesyndrome). On MRI, symmetric lesions, particularly in the basal ganglia, thalamus, or brainstem can be found 29 . Leigh syndrome is the MID with the widest genetic heterogeneity of all MIDs and may be due to mutations in the SURF1, NDUFS1-8, or NDUFV1-2 genes (Table 4) 29 .
Autosomal dominant chronic external ophthalmoplegia (AD-CPEO)
Autosomal dominant chronic external ophthalmoplegia may not only be restricted to the extra-ocular muscles but may also involve other systems, manifesting as proximal muscle weakness and wasting, hearing loss, or cerebellar ataxia (Table 3) 46 . Multiple mtDNA deletions may be found in the skeletal muscle of these patients 46 . Responsible for the multiple mtDNA deletions are mutations in the ANT1, C10orf2 (twinkle), or POLG1 genes 47 .
Autosomal recessive chronic external ophthalmoplegia (AR-CPEO)
Rarely, ataxia may be also a feature of AR-CPEO, such as in a family with CPEO, polyneuropathy, sensorineural hearing loss, and affective disorder 48 . The syndrome was due to two heterozygous missense transitions in the POLG1 gene 48 .
Sensory ataxia with neuropathy, dysarthria and ophthalmoparesis (SANDO)
AR Sensory ataxia with neuropathy, dysarthria and ophthalmoparesis syndrome was first reported in 1997 49 . Clinically, it is characterized by the triad of sensory or cerebellar ataxia, dysarthria, and ophthalmoparesis 49 . Additionally, there may be dysphagia, neuropathy or myopathy 50 . Genotypically, multiple mtDNA deletions due to POLG1 mutations 49, 50 or more rarely C10orf2 (twinkle) mutations are made responsible for the phenotype 51 .
Spino-cerebellar ataxia and epilepsy (SCAE)
Juvenile-onset SCAE is characterised by a phenotype resembling that of a spinocerebellar ataxia with the difference that SCAE patients also develop seizures 52 . Most frequently SCAE is due to mutations in the POLG1, C10orf2 (twinkle), or ANT1 genes respectively 52 . A patient with CPEO and multiple mtDNA deletions additionally developed sensory and cerebellar ataxia peripheral neuropathy, parkinsonism, and depression. The complex phenotype in this patient resembled SCAE and was attributed to mutations in ANT1 and POLG1 genes with deleterious, secondary effects on mtDNA maintenance and integrity 52 .
Alpers-Huttenlocher disease (AHS)
Alpers-Huttenlocher disease starts in the first years of life with sudden onset intractable seizures, developmental delay, psychomotor regression, stroke-like episodes, muscle hypotonia, ataxia, cortical blindness, hepatic failure, fasting hypoglycemia, and death within a short time 53, 54 . Muscle biopsy shows COXnegative fibers 55 . Neuropathological investigations reveal cortical gliosis and subcortical loss of neurons, particularly in the thalamus 55 . Alpers-Huttenlocher disease is due to mutations in the POLG1 gene, secondarily causing mtDNA depletion 56 . The diagnosis is established by liver biopsy, muscle biopsy, or genetic testing. A phenotype similar to AHS, including muscle hypotonia, athetosis, sensory neuropathy, ataxia, hypoacusis, ophthalmoplegia, and intractable epilepsy was caused by C10orf2 (twinkle) mutations, resulting in hepatic mtDNA depletion 57 .
Mitochondrial neuro-gastro-intestinal encephalomyopathy (MNGIE)
Mitochondrial neuro-gastro-intestinal encephalomyopathy is an AR MID, characterized by nausea, vomiting, diarrhea ascites, gastrointestinal dysmotility, ophthalmoparesis, neuropathy, and mitochondrial myopathy 58 . Complementary features include ataxic gait, hearing loss, short stature, facial palsy, dysphonia, dysarthria, sweating, orthostatic hypotension, bladder dysfunction and hepatosplenomegaly 58 . Mitochondrial neurogastro-intestinal encephalomyopathy is due to mutations in the gene encoding for the thymidine-phosphorylase 59, 60 , which plays an important role in the nucleoside metabolism by regulating the availability of thymidine for mitochondrial DNA synthesis 61 . The mutation secondarily causes mtDNA depletion or multiple mtDNA deletions. Thymidine-phosphorylase is also implicated in angiogenesis and cell trophism 62 .
X-linked sideroblastic anemia with ataxia (XLSA/A)
X-linked sideroblastic anemia with ataxia is a rare syndromic MID, characterized by mild sideroblastic anemia with hypochromia and microcytosis and cerebellar ataxia (Table 3) [63] [64] [65] . Cerebral imaging shows severe cerebellar atrophy. XLSA/A is THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES due to mutations in the mitochondrial ATP-binding cassette transporter ABC7 gene on chromosome Xq13 64, 66 .
Autosomal dominant optic atrophy and deafness (ADOAD)
Ataxia may be also a feature of ADOAD syndrome, which additionally presents with ataxia, axonal, sensorimotor neuropathy, CPEO, or mitochondrial myopathy (dominant optic atrophy "plus" syndrome) 67 . Muscle biopsy may show mosaic COX-deficiency 68 . The syndrome is due to mutations in the OPA1 gene, encoding for a dynamin-related GTPase, involved in mitochondrial fusion, cristae organization, and apoptosis 67, 69 . Affected patients also harbor multiple mtDNA deletions, suggesting that OPA1 is involved in mtDNA stability 67 . At onset OPA1 mutations may manifest exclusively as optic atrophy but during the disease course most patients develop ADOAD 68 .
Infantile-onset spinocerebellar ataxia (IOSCA)
AR Infantile-onset spinocerebellar ataxia is clinically characterized by cerebellar ataxia, epilepsy, athetosis, hypotonia, hypoacusis, CPEO, hypogonadism, and sensory neuropathy (Table 3) 70, 71 . Cerebral imaging may show progressive atrophy of the cerebellum, brainstem, or spinal cord 71 . Pathoanatomic studies confirm atrophy of the cerebellum, brainstem and, most severely, spinal cord 70 . IOSCA is caused by mutations in the C10orf2/PEO1 gene leading to an amino acid exchange in the mitochondrial helicase twinkle 72 . The mutation secondarily results in depletion of mtDNA in the brain and liver, which is why IOSCA is regarded as a depletion syndrome 72 . Biochemically, there is deficiency of RC complex I and IV 72 . In children there may be mtDNA depletion without demonstration of any mutation 73 .
Mitochondrial autosomal recessive ataxia syndrome (MIRAS)
Mitochondrial autosomal recessive ataxia syndrome is a common cause of AR juvenile-or adult-onset ataxia 74 . MIRAS is caused by homozygous or compound heterozygous mutations in the POLG1 gene resulting in multiple mtDNA deletions and to a lesser degree than in IOSCA also to mtDNA depletion 72 . Multiple mtDNA deletions are particularly present in the brain of these patients 72 . Biochemically, there is reduced activity of RC complex I and IV. In a study on 27 MIRAS patients they presented with ataxia, peripheral neuropathy, dysarthria, mild cognitive impairment, involuntary movements, psychiatric symptoms, and epileptic seizures 75 . Because of the high carrier frequency in Finland, the high number of patients in Norway, and an ancient European founder chromosome, MIRAS should be considered as a first-line differential diagnosis of progressive ataxia syndromes in Europe 75 .
Myoclonus epilepsy, mitochondrial myopathy, and sensory ataxia (MEMSA)
Myoclonus epilepsy, mitochondrial myopathy, and sensory ataxia patients present clinically with myoclonus epilepsy, mitochondrial myopathy, and sensory ataxia 6 . Myoclonus epilepsy, mitochondrial myopathy, and sensory ataxia is due to mutations in the POLG1 gene. In addition to MEMSA, POLG1 mutations cause myo-cerebro-hepatho spectrum (MCHS) disorders (SANDO, AHS), ataxia neuropathy spectrum (ANS) disorders (SCAE, MIRAS), AR-CPEO, and AD-CPEO 6 .
Leucencephalopathy with brainstem and spinal cord involvement, and lactacidosis (LBSL)
AR leucencephalopathy with brainstem and spinal cord involvement, and lactacidosis syndrome, a newly described entity, is clinically characterized by slowly progressive cerebellar ataxia, spasticity and dorsal column dysfunction 76 . Sometimes mild cognitive impairment may additionally develop. There is a highly characteristic constellation of abnormalities on cMRI 76 . The disorder is caused by mutations in the DARS2 gene, which encodes for the mitochondrial aspartyl-tRNA synthetase 76 . Though activity of this mitochondrial protein is reduced in affected patients, function of the RC is intact 76 .
Diabetes insipidus, diabetes mellitus, optic atrophy, and deafness (DIDMOAD)
Diabetes insipidus, diabetes mellitus, optic atrophy, and deafness or Wolfram syndrome (WFS) is a rare AR neurodegenerative disorder with juvenile onset 77 . The phenotype is characterized by diabetes and optic atrophy. Other less frequent features comprise psychiatric abnormalities, ataxia, urinary tract atony, limited joint contractures, cardiovascular and gastrointestinal autonomic neuropathy, hyper-gonadotropic hypogonadism, cardiac malformations, or pituitary dysfunction 77, 78 . Wolfram syndrome is due to mutations in the WFS1 gene on chromosome 4p16 or mutations in the WFS2 gene on chromosome 4q22-24 79, 80 . WSF1 and WSF2 mutations secondarily result in single or multiple mtDNA deletions 81 .
Coenzyme-Q (CoQ)-deficiency
Coenzyme-Q (CoQ)-deficiency is a genetically heterogenous disorder, presenting with four distinct phenotypes: a pure myopathic form, a severe infantile neurologic syndrome with nephritis, LS, or an ataxic variant 82 . Patients with the ataxic form present with epilepsy, weakness, cerebellar ataxia, cerebellar atrophy, migraine, myoglobinuria, or developmental delay 83 . The ataxic variant is the most common form characterized by cerebellar atrophy and cerebellar ataxia. Biochemically, there is deficiency of CoQ in muscle or fibroblasts. CoQ-deficiency responds well to CoQ-substitution 82 .
Pyruvate-dehydrogenase complex (PDC)-deficiency
The PDC converts pyruvate into acetyl-CoA within the mitochondrion. Mutations in the PDHA1 gene may cause recurrent episodes of isolated ataxia in infancy 84 . Though patients gain full recovery between the episodes, they later develop severe encephalopathy and die in their twenties 84 . Ataxia in patients with PDC-deficiency due to mutations in the E1beta subunit (PDHB) is usually less pronounced than in patients carrying PDHA1 mutations 85 .
Dilated cardiomyopathy with ataxia (DCMA)
Dilated cardiomyopathy with ataxia was first described in a family from the Canadian Dariusleut Hutterite population 86 conduction defects, non-progressive cerebellar ataxia, testicular dysgenesis, growth failure, and 3-methylglutaconic aciduria 86 . The causative mutation was the point mutation IVS3-1 G>C in the DNAJC19 gene, encoding a DNAJ domain containing protein. The DNAJC19 protein is located inside mitochondria of cardiomyocytes, and shares sequence and organisational similarity with proteins from several species including the two yeast mitochondrial inner membrane proteins, Mdj2p and Tim14, suggesting that the phenotype of DCMA is the result of defective mitochondrial protein import 86 .
Friedreich ataxia (FA)
AR Friedreich ataxia is clinically characterized by cerebellar ataxia, spasticity, pyramidal signs, hypertrophic cardiomyopathy, and Friedreich's foot deformity (pes cavus) 87 . Additional features may include headache, dysarthria, dysphagia, vertigo, weakness, chorea, or anemia 88, 89 . Scoliosis is found in two thirds of the cases and diabetes mellitus in one third 88 . Friedreich ataxia is the most common of the inherited ataxias. Friedreich ataxia is caused by a homozygous expansion of a GAA triplet repeat (96% of the cases) or point mutations, located within intron 1 of the frataxin gene on chromosome 9q13 87, 88 . Four percent of the patients are compound heterozygous, carrying a GAA expansion on one allele and a point mutation on the other 88 . Frataxin is a widely expressed mitochondrial protein, involved in RNA processing and intra-mitochondrial iron handling 87 and directly involved in mitochondrial iron-binding and detoxification 90 . Frataxin mutations cause frataxin deficiency, which leads to iron accumulation and overload, increased sensitivity to oxidative stress, and deficient RC-activity 87, 90 . Frataxin deficiency impairs mitochondrial functions either by a defect of iron/sulphur cluster construction or by the generation of free radicals.
Non-syndromic MID
Non-syndromic MIDs due to nDNA mutations are the most prevalent group of MIDs and genetically heterogenous. They comprise all those MIDs, which do not fit into the phenotype of any of the mitochondrial syndromes. As with syndromic MIDs the CNS is frequently involved and ataxia may be a dominant feature.
Among three patients carrying a mutation in the MPV17 gene, resulting in hepatocerebral mtDNA depletion, two had severe, progressive liver disease, and the third patient a milder form but developed progressive ataxia 91 . In a patient simultaneously carrying a POLG1 and ANT1 mutation resulting in multiple mtDNA deletions, the phenotype included CPEO, sensory and cerebellar ataxia, neuropathy, parkinsonism and depression 52 . A POLG1 mutation also caused a phenotype with sensory ataxia, myoclonus, epilepsy, cognitive decline, nystagmus, dysarthria, and thalamic and cerebellar white matter lesions on MRI 92 . Another POLG1 mutation caused CPEO, polyneuropathy, ataxia, sensorineural hearing loss, and affective disorder 48 . In single cases the common ATP6 mutation 8993T>C may not only cause NARP or LS but may also manifest as adult onset ataxia and polyneuropathy 93 . Ataxia was also a phenotypic feature in a patient carrying a tRNAGlu mutation. He additionally presented with exercise intolerance, weakness, and lactic acidosis 43 . Cerebellar ataxia was also a phenotypic feature in a 7-year-old male with CPEO, spasticity, and dystonia attributed to RC complex I deficiency due to a NDUFV1 mutation 94 . This mutation may be also associated with maternally inherited episodic ataxia 93 . In a study on five European MID families ataxia occurred in combination with various other CNS abnormalities. Cerebral MRI showed thalamic and cerebellar white matter lesions and autopsy neuronal loss in gray nuclei 92 . In eight patients the abnormalities could be attributed to AR POLG1 mutations 92 .
DISCUSSION
This review supports the notion that ataxia may be a more or less prominent feature of syndromic or non-syndromic MIDs either due to mutations in mtDNA or nDNA located genes. Mitochondrial disorders are associated with cerebellar as well as sensory ataxia and both may be present within the same patient or family. Mitochondrial disorders with ataxia are increasingly recognized and should be included in the differential diagnoses or classification of classical heredoataxias. This study also confirms that most MIDs do not nicely fit into one of the original acronyms but rather represent individual phenotypes, which more or less overlap with classical mitochondrial syndromes. Despite limited therapeutic options, neurologists should be aware of ataxia as a feature of MIDs, since it may guide them to the correct diagnosis, particularly if other neurological or nonneurological manifestations of a MID are present. Limitations of this study were that not all papers were accessible, that most studies did not clearly differentiate between cerebellar and sensory ataxia, and that most studies neither quantified the degree of ataxia nor described the course or outcome of the individual phenotypes.
CONCLUSION
This mini review shows that ataxia is a dominant feature of some MIDs with cerebral involvement. Cerebellar as well as sensory ataxia may occur in MID patients and may contribute to the disability in some of these patients. Ataxia is much more frequent in non-syndromic as compared to syndromic MIDs. As soon as ataxia is detected in patients with a phenotpye suggesting a MID, they should undergo a compreshensive neurological investigation, including cerebral imaging studies.
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